Aimfinity Investment Corp. Faces Nasdaq Delisting

Aimfinity Investment Corp. has received a delisting notice from Nasdaq and will be suspended from trading on May 5, 2025. Its securities will then begin trading on the OTC Markets under the tickers "AIMAU," "AIMBU," and "AIMAW."

Aimfinity Investment Corp. I (AIMA) has announced its forthcoming delisting from Nasdaq, effective May 5, 2025, following a notice from the exchange. The company's securities will move to the OTC Markets under new tickers: "AIMAU" for units, "AIMBU" for new units, and "AIMAW" for warrants.

The delisting will not materially affect AIMA's planned business combination with Taiwanese health technology firm Docter Inc., which has already received shareholder approval. To extend the deadline for the merger until May 28, 2025, AIMA's sponsor made a deposit into its trust account. The company remains focused on completing the business transaction and securing a future Nasdaq listing for the merged entity.

AIMA's securities will be suspended from Nasdaq and begin trading on the OTC Markets under the new tickers. The delisting indicates a significant loss of prestige and accessibility for its investors, but AIMA remains committed to achieving Nasdaq listing approval for the post-combined entity.

References:
[1] https://www.nasdaq.com/articles/aimfinity-investment-corp-i-announces-nasdaq-delisting-and-continued-business-combination